Sign inJoin waitlistJoin the waitlist

Ram Subramanian

Physician · Emory University School of Medicine

Credentials: · · · ·

History

Emory University School of Medicine
Present

Transplant Hepatology
Emory University
2009–2010
University of Chicago
2006–2009
Pulmonary Disease and Critical Care Medicine
University of Chicago Medical Center
2003–2006
Pathology
University of Nebraska Medical Center
2001–2002
Internal Medicine
University of Chicago Medical Center
1998–2001
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1994–1998

Research

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures
Hepatology · 2014 · 487 citations
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD)…
Hepatology · 2012 · 354 citations
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study
Annals of Internal Medicine · 2016 · 318 citations

Jacqueline O'Leary
31 papers
JB
Jasmohan Bajaj
30 papers
Patrick Kamath
30 papers
GG
Guadalupe Garcia-Tsao
29 papers
KR
Kuchikula Reddy
28 papers
Michael Fallon
23 papers
BM
Benedict Maliakkal
22 papers
PT
Paul Thuluvath
22 papers
Scott Biggins
22 papers
Hugo Vargas
21 papers
Jennifer Lai
19 papers · 9 as a fellow
JO
Jody Olson
16 papers

Clinical trials

Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
Principal investigator · Terminated · Phase 3
Vital Therapies, Inc.
2016–2018
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
Principal investigator · Terminated · Phase 2
Vital Therapies, Inc.
2014–2018
To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure
Principal investigator · Terminated · Phase 3
Vital Therapies, Inc.
2014–2018
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
Principal investigator · Completed · Phase 3
Vital Therapies, Inc.
2013–2015